Canities

3

Review clinical trials related to Canities. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair

This will be a 6-month randomized, double-blind, placebo-controlled trial. A total of 152 participants with hair loss, including some with gray hair, will be enrolled and randomly assigned to four groups. Each group will receive a combination of oral capsules and hair tonic, to be used as directed for 24 weeks. Participants will attend three in-person visits, during which assessments-including hair-related tests and photographs-will be conducted to evaluate hair count and density. Additionally, 10 participants with gray hair from each group will undergo extra assessments focused on changes in hair color. All relevant clinical data will be systematically collected and recorded for statistical analysis.

Participants needed: 152
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Vita Green Pharmaceutical (H.K.) Ltd.Updated: Sep 19, 2025Locations: 1
Eligibility criteria

Participants must sign the informed consent form prior to enrollment and fully u... [+6]

Pregnant or breastfeeding women, or individuals planning to conceive in the near... [+10]

Status: Not yet recruiting

Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)

Clinical Study to Assess the Safety and Efficacy of CS-002 (mTOR inhibitor) as a treatment for Canities (Grey Hair)

Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 30-65Biological sex: AllType: InterventionalSponsor: Applied Biology, Inc.Updated: Sep 10, 2025
Eligibility criteria

Age 30 to 65 [+4]

A medical history that may interfere with study objectives [+7]

Status: Not yet recruiting

Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)

Clinical Study to Assess the Safety and Efficacy of CS-001 as a treatment for Canities (Grey Hair)

Participants needed: 240
Trial details
Phase: Phase 3Age: 30-65Biological sex: AllType: InterventionalSponsor: Applied Biology, Inc.Updated: Dec 24, 2024
Eligibility criteria

Age 30 to 65 [+4]

A medical history that may interfere with study objectives [+7]